Stacie Stone - Revision history

Maureen E. Hoatlin at 06:32, 14 February 2009

2009-02-14T06:32:13Z

←Older revision		Revision as of 06:32, 14 February 2009
Line 1:		Line 1:
	'''Stacie Stone, Ph.D.		'''Stacie Stone, Ph.D.
-	~~<br>Training Program in Molecular Hematology/Oncology, Postdoctoral Fellowship '''~~	+
-	~~<br>Contact: stonest AT ohsu DOT edu~~	+

	Stacie received her Ph.D. in Human Genetics at the Vrije University, Amsterdam, The Netherlands in 2008 after earning her B.S. in Molecular Biology/Biotechnology from Portland State University in 2000. She arrived at OHSU in October of 1998.		Stacie received her Ph.D. in Human Genetics at the Vrije University, Amsterdam, The Netherlands in 2008 after earning her B.S. in Molecular Biology/Biotechnology from Portland State University in 2000. She arrived at OHSU in October of 1998.

Stacie: /* Abstracts/Talks */

2008-10-02T20:42:41Z

Abstracts/Talks

←Older revision		Revision as of 20:42, 2 October 2008
Line 35:		Line 35:
	[[Image:FA03.jpg\|thumb\|left\|FA Research Symposium, Houston, Texas 2003]]		[[Image:FA03.jpg\|thumb\|left\|FA Research Symposium, Houston, Texas 2003]]

		+
		+	*ASH conference, San Francisco 2008

	*[[:media:FARFab07.pdf\|FA Research Symposium, Chicago, Illinois 2007]]		*[[:media:FARFab07.pdf\|FA Research Symposium, Chicago, Illinois 2007]]
Line 48:		Line 50:
	*[[:media:FA03.pdf\|FA Research Symposium, Houston, Texas 2003]]		*[[:media:FA03.pdf\|FA Research Symposium, Houston, Texas 2003]]

-	*[[:media:ASH03.pdf\|Ash 2003]]	+	*[[:media:ASH03.pdf\|Ash Conference 2003]]

	*[[:media:FA01.pdf\|FA Research Symposium, Portland, Oregon 2001]]		*[[:media:FA01.pdf\|FA Research Symposium, Portland, Oregon 2001]]
-

	==Visiting Scholar==		==Visiting Scholar==

Stacie: /* Visiting Student */

2008-10-02T20:40:39Z

Visiting Student

←Older revision		Revision as of 20:40, 2 October 2008
Line 53:		Line 53:


-	==Visiting ~~Student~~==	+	==Visiting Scholar==

-		+	*2008 Visiting Scientist, University of California, Berkeley, California Laboratory of Dr. Rebecca Heald
-	*~~2003~~ Visiting Scientist, ~~Free~~ University of ~~Amsterdam~~, ~~The Netherlands~~ Laboratory of Dr. ~~Hans Joenje~~	+

	*2005 Visiting Scientist, National Institute of Health, Baltimore, Maryland Laboratory of Dr. Weidong Wang		*2005 Visiting Scientist, National Institute of Health, Baltimore, Maryland Laboratory of Dr. Weidong Wang
		+
		+	*2003 Visiting Scientist, Free University of Amsterdam, The Netherlands Laboratory of Dr. Hans Joenje

	==Education==		==Education==

Stacie at 20:38, 2 October 2008

2008-10-02T20:38:46Z

←Older revision		Revision as of 20:38, 2 October 2008
Line 1:		Line 1:
-	'''Stacie Stone, Ph.D. Training Program in Molecular Hematology/Oncology, Postdoctoral Fellowship '''	+	'''Stacie Stone, Ph.D.
		+	<br>Training Program in Molecular Hematology/Oncology, Postdoctoral Fellowship '''
	<br>Contact: stonest AT ohsu DOT edu		<br>Contact: stonest AT ohsu DOT edu

Stacie at 20:38, 2 October 2008

2008-10-02T20:38:14Z

←Older revision		Revision as of 20:38, 2 October 2008
Line 1:		Line 1:
-	'''Stacie Stone, Ph.D. Postdoctoral ~~Fellow~~'''	+	'''Stacie Stone, Ph.D. Training Program in Molecular Hematology/Oncology, Postdoctoral Fellowship '''
	<br>Contact: stonest AT ohsu DOT edu		<br>Contact: stonest AT ohsu DOT edu

Stacie: /* Publications */

2008-10-02T20:34:27Z

Publications

←Older revision		Revision as of 20:34, 2 October 2008
Line 18:		Line 18:
	==Publications==		==Publications==
	#Igor Landais, Alexandra Sobeck, '''Stacie Stone*''', Alexis LaChapelle, Maureen E. Hoatlin. '''A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.''' International Journal of Cancer 2008 (In press) [http://www3.interscience.wiley.com/cgi-bin/fulltext/121427598/PDFSTART PDF Preprint]		#Igor Landais, Alexandra Sobeck, '''Stacie Stone*''', Alexis LaChapelle, Maureen E. Hoatlin. '''A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.''' International Journal of Cancer 2008 (In press) [http://www3.interscience.wiley.com/cgi-bin/fulltext/121427598/PDFSTART PDF Preprint]
		+	# Lily Chien Wang, '''Stacie Stone''', Maureen E Hoatlin and Jean Gautier. '''Fanconi anemia proteins stabilize replication forks.''' DNA repair 2008 (In press) [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6X17-4THS3JX-2&_user=1072900&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000048262&_version=1&_urlVersion=0&_userid=1072900&md5=1e36066016e3aa62230ae9e1bf171f01 PDF Preprint]
	#'''Stone, S.''', Sobeck, A., van Kogelenberg M., de Graaf B., Joenje H., Christian J., and Hoatlin ME. '''Identification, Developmental Expression, and Regulation of the Xenopus Ortholog of Human FANCG/XRCC9.''' Genes to Cells 2007 Jul;12(7):841–851. [http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2443.2007.01096.x abstract]		#'''Stone, S.''', Sobeck, A., van Kogelenberg M., de Graaf B., Joenje H., Christian J., and Hoatlin ME. '''Identification, Developmental Expression, and Regulation of the Xenopus Ortholog of Human FANCG/XRCC9.''' Genes to Cells 2007 Jul;12(7):841–851. [http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2443.2007.01096.x abstract]
	#Sobeck, A, '''Stone, S.''', Hoatlin, ME. '''DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein, FANCD2.''' 2007 Jun;27(12):4283-92. [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17420278&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum abstract]		#Sobeck, A, '''Stone, S.''', Hoatlin, ME. '''DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein, FANCD2.''' 2007 Jun;27(12):4283-92. [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17420278&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum abstract]

Stacie: /* Publications */

2008-10-02T20:30:21Z

Publications

←Older revision		Revision as of 20:30, 2 October 2008
Line 17:		Line 17:

	==Publications==		==Publications==
-		+	#Igor Landais, Alexandra Sobeck, '''Stacie Stone*''', Alexis LaChapelle, Maureen E. Hoatlin. '''A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.''' International Journal of Cancer 2008 (In press) [http://www3.interscience.wiley.com/cgi-bin/fulltext/121427598/PDFSTART PDF Preprint]
	#'''Stone, S.''', Sobeck, A., van Kogelenberg M., de Graaf B., Joenje H., Christian J., and Hoatlin ME. '''Identification, Developmental Expression, and Regulation of the Xenopus Ortholog of Human FANCG/XRCC9.''' Genes to Cells 2007 Jul;12(7):841–851. [http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2443.2007.01096.x abstract]		#'''Stone, S.''', Sobeck, A., van Kogelenberg M., de Graaf B., Joenje H., Christian J., and Hoatlin ME. '''Identification, Developmental Expression, and Regulation of the Xenopus Ortholog of Human FANCG/XRCC9.''' Genes to Cells 2007 Jul;12(7):841–851. [http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2443.2007.01096.x abstract]
	#Sobeck, A, '''Stone, S.''', Hoatlin, ME. '''DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein, FANCD2.''' 2007 Jun;27(12):4283-92. [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17420278&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum abstract]		#Sobeck, A, '''Stone, S.''', Hoatlin, ME. '''DNA Structure-Induced Recruitment and Activation of the Fanconi Anemia Pathway Protein, FANCD2.''' 2007 Jun;27(12):4283-92. [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17420278&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum abstract]

Stacie at 20:36, 28 August 2008

2008-08-28T20:36:53Z

←Older revision		Revision as of 20:36, 28 August 2008
Line 1:		Line 1:
-	~~[[Image:Stacie.jpg\|left\|thumb\|Contact: <br>stonest AT ohsu DOT edu]]~~
-
	'''Stacie Stone, Ph.D. Postdoctoral Fellow'''		'''Stacie Stone, Ph.D. Postdoctoral Fellow'''
		+	<br>Contact: stonest AT ohsu DOT edu

	Stacie received her Ph.D. in Human Genetics at the Vrije University, Amsterdam, The Netherlands in 2008 after earning her B.S. in Molecular Biology/Biotechnology from Portland State University in 2000. She arrived at OHSU in October of 1998.		Stacie received her Ph.D. in Human Genetics at the Vrije University, Amsterdam, The Netherlands in 2008 after earning her B.S. in Molecular Biology/Biotechnology from Portland State University in 2000. She arrived at OHSU in October of 1998.

Stacie: /* Research */

2008-05-22T00:49:25Z

Research

←Older revision		Revision as of 00:49, 22 May 2008
Line 7:		Line 7:


-	==Research==	+	==Research Interest: Molecular Mechanism of Human Cancer Susceptibility==
	[[Image:Intro-fig1_FA_pathway.jpg\|thumb\|The Fanconi Anemia pathway]]		[[Image:Intro-fig1_FA_pathway.jpg\|thumb\|The Fanconi Anemia pathway]]
	‘Caretaker’ type gene diseases, such as Fanconi Anemia (FA), provide an opportunity to understand the fundamental mechanisms of host susceptibility to cancer. Unlike many caretaker gene diseases, where the defects have been associated with specific molecular processes, the precise underlying molecular defect in FA is unknown.		‘Caretaker’ type gene diseases, such as Fanconi Anemia (FA), provide an opportunity to understand the fundamental mechanisms of host susceptibility to cancer. Unlike many caretaker gene diseases, where the defects have been associated with specific molecular processes, the precise underlying molecular defect in FA is unknown.

Stacie at 00:44, 22 May 2008

2008-05-22T00:44:40Z

←Older revision		Revision as of 00:44, 22 May 2008
Line 13:		Line 13:
	Although recent developments in the FA field have furthered our understanding of the FA pathway and its role in genomic stability, there are still unidentified FA patient groups, which means there are still unidentified FA genes. Until all the FA proteins, their complexes, and other important functional cofactors that impact the FA pathway are identified we are missing necessary pieces to complete the FA pathway puzzle.		Although recent developments in the FA field have furthered our understanding of the FA pathway and its role in genomic stability, there are still unidentified FA patient groups, which means there are still unidentified FA genes. Until all the FA proteins, their complexes, and other important functional cofactors that impact the FA pathway are identified we are missing necessary pieces to complete the FA pathway puzzle.

-	* <font color="red">~~My current~~ focus:</font> To identify functionally important proteins and protein complexes within the FA pathway.	+	* <font color="red">Current focus:</font> To identify functionally important proteins and protein complexes within the FA pathway.

	* <font color="red">Long-term goal:</font> Identify functionally important proteins within the FA pathway to aid in the development of cell-free screens for small molecules that could translate into therapeutics for FA patients.		* <font color="red">Long-term goal:</font> Identify functionally important proteins within the FA pathway to aid in the development of cell-free screens for small molecules that could translate into therapeutics for FA patients.

←Older revision		Revision as of 20:42, 2 October 2008
Line 35:		Line 35:
	[[Image:FA03.jpg\|thumb\|left\|FA Research Symposium, Houston, Texas 2003]]		[[Image:FA03.jpg\|thumb\|left\|FA Research Symposium, Houston, Texas 2003]]

		+
		+	*ASH conference, San Francisco 2008

	*[[:media:FARFab07.pdf\|FA Research Symposium, Chicago, Illinois 2007]]		*[[:media:FARFab07.pdf\|FA Research Symposium, Chicago, Illinois 2007]]
Line 48:		Line 50:
	*[[:media:FA03.pdf\|FA Research Symposium, Houston, Texas 2003]]		*[[:media:FA03.pdf\|FA Research Symposium, Houston, Texas 2003]]

-	*[[:media:ASH03.pdf\|Ash 2003]]	+	*[[:media:ASH03.pdf\|Ash Conference 2003]]

	*[[:media:FA01.pdf\|FA Research Symposium, Portland, Oregon 2001]]		*[[:media:FA01.pdf\|FA Research Symposium, Portland, Oregon 2001]]
-

	==Visiting Scholar==		==Visiting Scholar==